JENNIFER DECAROLIS: Open Payments
NPI 1972905909 · ATTLEBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 18 payments from 5 companies in 2025. Trend: 2023 $180 · 2024 $664 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 3 | $196 |
| Sumitomo Pharma America, Inc. | 6 | $135 |
| Astellas Pharma US Inc | 3 | $82 |
| Sage Therapeutics, LLC | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
Products named: SLYND, GEMTESA, Veozah, ZURZUVAE, MYFEMBREE, Mirena, Lynkuet.
Industry payments across MA — which companies pay providers there.
